SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns blowout quarterly results and stronger outlook, supported by AI-driven memory demand and expectations of tight supply through fiscal 202728, are driving attention. Bulls see durable growth, while others question the muted share-price reaction and cite priced-in expectations, memory-cycle risk, higher spending and rising yields.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is drawing attention amid a sharp selloff in long-duration Treasuries as yields reach multi-decade highs, weighing on bond prices. Traders are split between expecting further declines amid inflation, debt concerns and rate-hike risks, and seeing oversold conditions and higher yields as a buying opportunity.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBMs self-hosted deployment for its Bob agentic development platform is drawing attention, offering enterprises on-premises and air-gapped options to keep sensitive code and data under their control. Traders are reacting positively to the AI-software announcement, though some expect the initial move to fade.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

Traders are reacting to the reported Panasonic Advanced TechnologyJasmy/JANCTION Smart Render collaboration, with discussion highlighting a working rendering product and plans for commercialization. Bulls see the development as evidence of progress in Jasmys AI and GPU ecosystem, while skeptics question whether it will drive meaningful JASMY adoption or token demand and point to exchange-delisting concerns.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accentures quarterly earnings beat, record bookings and fiscal-year outlook are driving a sharp rally. Many traders see the results as easing concerns about AI disrupting consulting demand, while skeptics argue those longer-term risks remain.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

A Delaware court ruled that Yutrepia infringes two United Therapeutics patent claims covering its PH-ILD use, driving a sharp selloff as traders weigh possible label removal or broader sales restrictions. Liquidia plans to appeal and pursue a narrower label; the community is split between viewing the drop as an overreaction and seeing substantial uncertainty for the drugs commercial prospects.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRXs high-volume breakout and push through resistance are driving attention, with traders debating whether the move reflects momentum and institutional buying or anticipation of undisclosed news. Many are bullish on Anktivas pending bladder-cancer label expansion and discuss short-squeeze potential, while others caution that the rally could fade without a confirmed new announcement.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Labs largest-ever commercial Electron agreementa 20-launch deal with Synspectivehas drawn attention for adding to its launch backlog, alongside Citis bullish initiation of coverage. Traders largely view the contract as a sign of demand and business momentum, while others question its undisclosed value and margins and warn the stock could give back gains; Neutron delays and volatile price action remain points of concern.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Reports that Evernorths merger vote with Armada passed have fueled a sharp move in XRPN, with traders focused on the planned XRP-treasury company and its eventual listing structure. Optimism about XRP exposure and warrant upside is tempered by uncertainty over official vote details, redemptions, dilution, and the mergers closing timeline.

Synopsys, Inc. engages in the provision of electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs). It also offers semiconductor intellectual property (IP) products. It operates through the Design Automation and Design IP segments. The Design Automation segment includes silicon design, verification of products and services, and Ansys products, and system integration of products and services. The Design IP segment refers to interface, foundation, security, and embedded processor IP, IP subsystems, and IP implementation services that serve companies primarily in the semiconductor and electronics industries. The company was founded by Aart J. de Geus, Bill Krieger, Dave Gregory, and Rick Rudell in December 1986 and is headquartered in Sunnyvale, CA.

Synopsys, Inc.

Synopsys Inc

Synopsys investor-day growth and margin targets, alongside analyst estimate increases, are driving attention; traders also point to expanded AWS chip-design work and an OpenAI collaboration as potential AI-related growth drivers. The reaction is broadly constructive, though some remain cautious and want evidence that the targets and licensing-plus-royalty strategy will translate into sustained execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PFE presented Phase 2 atopic dermatitis data with strong EASI-75 results. https://www.rapidticker.com/news/pfe-pfizeraposs-tilrekimig-shows-significant-skin-6f7067

ApiL

Thomas Prindle

Pfizer&apos;s Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study - PFIZER INC (PFE) stock news on RapidTicker

RapidTicker

Pfizer&apos;s Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study - PFE | RapidTicker

StockTwits Web

Pfizer Inc

 presented Phase 2 atopic dermatitis data with strong EASI-75 results. 